Abiopharma

Iovance Biotherapeutics to Present Clinical Data for Lifileucel Tumor Infiltrating Lymphocyte (TIL) Therapy in Advanced Melanoma at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

Sensei Biotherapeutics to Present New Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

Immuneering To Present Poster on IMM-6-415 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022

(10% Negative) Vir Biotechnology, Inc. (VIR) Announces Delay in Administration Development Timeline Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(64% Neutral) QUANTUM-SI INCORPORATED (QSI) Reports Q4 2022 Financial Results

(99% Neutral) Summit Therapeutics Inc. (SMMT) Announces Clinical Development Update

(90% Positive) INHIBRX, INC. (INBX) Provides Update on markets for illustrative purposes o

COMPASS Pathways to Hold Virtual Capital Market Day on 12 October 2022

New Form 8-K for Quantum-Si Incorporated